Promoting exercise after a cancer diagnosis: easier said than done

gan Hudis, C A, Jones, L
Cyhoeddwyd 2014

Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907)

gan Ruddy, K. J., Pitcher, B. N., Archer, L. E., Cohen, H. J., Winer, E. P., Hudis, C. A., Muss, H. B., Partridge, A. H.
Cyhoeddwyd 2012

Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer

gan Baselga, J., Manikhas, A., Cortés, J., Llombart, A., Roman, L., Semiglazov, V. F., Byakhov, M., Lokanatha, D., Forenza, S., Goldfarb, R. H., Matera, J., Azarnia, N., Hudis, C. A., Rozencweig, M.
Cyhoeddwyd yn Ann Oncol (2014)

Corrections to “Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer”

gan Baselga, J., Manikhas, A., Cortés, J., Llombart, A., Roman, L., Semiglazov, V.F., Byakhov, M., Lokanatha, D., Forenza, S., Goldfarb, R.H., Matera, J., Azarnia, N., Hudis, C.A., Rozencweig, M.
Cyhoeddwyd yn Ann Oncol (2019)

A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer

gan Fornier, M. N., Morris, P. G., Abbruzzi, A., D'Andrea, G., Gilewski, T., Bromberg, J., Dang, C., Dickler, M., Modi, S., Seidman, A. D., Sklarin, N., Chang, J., Norton, L., Hudis, C. A.
Cyhoeddwyd yn Ann Oncol (2011)

Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer

gan Morris, P.G., Rota, S, Cadoo, K, Zamora, S, Patil, S, D’Andrea, G., Gilewski, T., Bromberg, J., Dang, C., Dickler, M., Modi, S., Seidman, A.D., Sklarin, N., Norton, L, Hudis, C.A., Fornier, M.N.
Cyhoeddwyd yn Clin Breast Cancer (2018)

Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival results from...

gan Smyth, L. M., Iyengar, N. M., Chen, M. F., Popper, S. M., Patil, S, Wasserheit-Lieblich, C., Argolo, D. F., Singh, J. C., Chandarlapaty, S, Sugarman, S. M., Comen, E. A., Drullinsky, P. R., Traina, T. A., Troso-Sandoval, T, Baselga, J, Norton, L, Hudis, C. A., Dang, C. T.
Cyhoeddwyd yn Breast Cancer Res Treat (2016)

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Tria...

gan Freedman, Rachel A., Seisler, D. K., Foster, J. C., Sloan, J. A., Lafky, J. M., Kimmick, G. G., Hurria, A., Cohen, H. J., Winer, E. P., Hudis, C. A., Partridge, A. H., Carey, L. A., Jatoi, A., Klepin, H. D., Citron, M., Berry, D. A., Shulman, L. N., Buzdar, A. U., Suman, V. J., Muss, H. B.
Cyhoeddwyd yn Breast Cancer Res Treat (2016)

Predicting response and survival in chemotherapy-treated triple-negative breast cancer

gan Prat, A, Lluch, A, Albanell, J, Barry, W T, Fan, C, Chacón, J I, Parker, J S, Calvo, L, Plazaola, A, Arcusa, A, Seguí-Palmer, M A, Burgues, O, Ribelles, N, Rodriguez-Lescure, A, Guerrero, A, Ruiz-Borrego, M, Munarriz, B, López, J A, Adamo, B, Cheang, M C U, Li, Y, Hu, Z, Gulley, M L, Vidal, M J, Pitcher, B N, Liu, M C, Citron, M L, Ellis, M J, Mardis, E, Vickery, T, Hudis, C A, Winer, E P, Carey, L A, Caballero, R, Carrasco, E, Martín, M, Perou, C M, Alba, E
Cyhoeddwyd 2014